JD
Therapeutic Areas
Spexis Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ColiFin® | Cystic Fibrosis | Phase 3 |
| Inhaled Murepavadin (OMPTA) | Gram-negative Bacterial Infections | Phase 1 |
| OMPTA (LPS/BamA) | Gram-negative Bacterial Infections | Pre-clinical |
| OMPTA (LptA Thanatin) | Gram-negative Bacterial Infections | Pre-clinical |
| Macrocycle Oncology Leads | Oncology | Pre-clinical |